Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Mol Cell Cardiol. 2015 Jun 10;85:215–225. doi: 10.1016/j.yjmcc.2015.06.003

Figure 1. Sfrp2 promotes differentiation of CPCs in vivo.

Figure 1

(A and B) Representative images and quantification of (A) Sca1-eGFP+ and Gata4+ cells and (B) Sca1-eGFP+ and Nkx2.5+ cells 7 days after ischemia-reperfusion injury (arrows point to Sca1-eGFP+Gata4+ and Sca1-eGFP+Nkx2.5+ cells respectively); n=7 saline, n=9 Sfrp2. * P≤0.05. (C) Representative images of immunofluorescence staining of newly formed tdTomato+cTnT+ cardiomyocytes in the infarct border zone of Sfrp2 treated heart with quantification. *P<0.05, compared to PBS treated animals; n=6 Sham, n=5 PBS, n=6 Sfrp2.